Literature DB >> 22285981

Transcription factories, chromatin loops, and the dysregulation of gene expression in malignancy.

Binwei Deng1, Svitlana Melnik, Peter R Cook.   

Abstract

Pathologists recognize and classify cancers according to nuclear morphology, but there remains little scientific explanation of why malignant nuclei possess their characteristic features, or how those features are related to dysregulated function. This essay will discuss a basic structure-function axis that connects one central architectural motif in the nucleus-the chromatin loop-to the vital nuclear function of transcription. The loop is attached to a "transcription factory" through components of the transcription machinery (either polymerases or transcriptional activators/repressors), and the position of a gene within a loop determines how often that gene is transcribed. Then, dysregulated transcription is tightly coupled to alterations in structure, and vice versa. We also speculate on how the experimental approaches being used to analyze loops and factories might be applied to study the problems of tumour initiation and progression.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285981     DOI: 10.1016/j.semcancer.2012.01.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  23 in total

1.  RNAs specifically affect gene expression in a length, position and sequence dependent manner.

Authors:  Jianjun Cheng; Xiufang Wang; Nianguang Cai; Zhihong Ma; Liyan Zhang; Zhanjun Lv
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 2.  SATB family chromatin organizers as master regulators of tumor progression.

Authors:  Rutika Naik; Sanjeev Galande
Journal:  Oncogene       Date:  2018-11-09       Impact factor: 9.867

Review 3.  Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders.

Authors:  Robert S Porter; Farris Jaamour; Shigeki Iwase
Journal:  Mol Cell Neurosci       Date:  2017-12-15       Impact factor: 4.314

4.  Hippocampal stimulation promotes intracellular Tip60 dynamics with concomitant genome reorganization and synaptic gene activation.

Authors:  Ashley Karnay; Bhanu Chandra Karisetty; Mariah Beaver; Felice Elefant
Journal:  Mol Cell Neurosci       Date:  2019-11-01       Impact factor: 4.314

Review 5.  Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Authors:  Sayyed K Zaidi; Andrew J Fritz; Kirsten M Tracy; Jonathan A Gordon; Coralee E Tye; Joseph Boyd; Andre J Van Wijnen; Jeffrey A Nickerson; Antony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Adv Biol Regul       Date:  2018-05-09

6.  Procedures for risk-stratification of lung cancer using buccal nanocytology.

Authors:  H Subramanian; P Viswanathan; L Cherkezyan; R Iyengar; S Rozhok; M Verleye; J Derbas; J Czarnecki; H K Roy; V Backman
Journal:  Biomed Opt Express       Date:  2016-08-31       Impact factor: 3.732

Review 7.  Temporal regulation of chromatin during myoblast differentiation.

Authors:  Akihito Harada; Yasuyuki Ohkawa; Anthony N Imbalzano
Journal:  Semin Cell Dev Biol       Date:  2017-10-28       Impact factor: 7.727

8.  WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating.

Authors:  Barbara A Scholz; Noriyuki Sumida; Anita Göndör; Rolf Ohlsson; Carolina Diettrich Mallet de Lima; Ilyas Chachoua; Mirco Martino; Ilias Tzelepis; Andrej Nikoshkov; Honglei Zhao; Rashid Mehmood; Emmanouil G Sifakis; Deeksha Bhartiya
Journal:  Nat Genet       Date:  2019-11-29       Impact factor: 38.330

9.  Transcription factor binding at enhancers: shaping a genomic regulatory landscape in flux.

Authors:  Robert-Jan Palstra; Frank Grosveld
Journal:  Front Genet       Date:  2012-09-28       Impact factor: 4.599

Review 10.  Epigenomics of cancer - emerging new concepts.

Authors:  Melanie R Hassler; Gerda Egger
Journal:  Biochimie       Date:  2012-05-17       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.